Adam Ioannou, Francesco Cappelli, Michele Emdin, Christian Nitsche, Simone Longhi, Ahmad Masri, Alberto Cipriani, Mattia Zampieri, Federica Colio, Michael Poledniczek, Aldostefano Porcari, Yousuf Razvi, Alberto Aimo, Giuseppe Vergaro, Laura De Michieli, Muhammad U Rauf, Rishi K Patel, Eugenia Villanueva, Yael Lustig, Lucia Venneri, Ana Martinez-Naharro, Helen Lachmann, Ashutosh Wechalekar, Carol Whelan, Aviva Petrie, Philip N Hawkins, Scott Solomon, Julian D Gillmore, Marianna Fontana
BACKGROUND: Transthyretin cardiac amyloidosis (ATTR-CA) is a progressive cardiomyopathy. The clinical course varies among individuals and there are no established measures to assess disease progression. OBJECTIVES: The goal of this study was to assess the prognostic importance of an increase in N-terminal pro-B-type natriuretic peptide (NT-proBNP) and outpatient diuretic intensification (ODI) as markers of disease progression in a large cohort of patients with ATTR-CA...
March 1, 2024: Journal of the American College of Cardiology